Elixinol Wellness Ltd
F:E8M
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (0.6), the stock would be worth €0 (40% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.4 | €0 |
0%
|
| 3-Year Average | 0.6 | €0 |
+40%
|
| 5-Year Average | 0.7 | €0 |
+60%
|
| Industry Average | 4.5 | €0.03 |
+915%
|
| Country Average | 2.7 | €0.02 |
+502%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| AU |
|
Elixinol Wellness Ltd
F:E8M
|
3.3m EUR | 0.4 | -0.6 | |
| FR |
|
L'Oreal SA
PAR:OR
|
201.5B EUR | 5.8 | 32.9 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
93.4B GBP | 6.9 | 11.3 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.6T INR | 11.2 | 37.6 | |
| UK |
|
HALEON PLC
LSE:HLN
|
31.6B GBP | 1.9 | 19 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
28.1B USD | 7 | -158.1 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
15.8B EUR | 1.8 | 16.8 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 2.5 | 22.2 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.2T INR | 9.6 | 64.1 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | -10 713 | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
815.9B INR | 7.3 | 43.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.6 |
| Median | 2.7 |
| 70th Percentile | 4.3 |
| Max | 2 199.4 |
Other Multiples
Elixinol Wellness Ltd
Glance View
Elixinol Wellness Ltd. engages in the sale of nutraceutical and related hemp products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2018-01-08. The firm is engaged in marketing and selling hemp derived nutraceutical, cosmetic and food products. The company focuses on building its consumer brand portfolio via its manufacturing, research and development (R&D), and sales and marketing teams. Its businesses include Elixinol and Hemp Foods Australia. The Elixinol is the hemp derived cannabidiol (CBD) brands. The firm develops, manufactures and sells CBD products to consumers across the Americas, United Kingdom, Europe and other parts of the world. The Hemp Foods Australia is the hemp food wholesalers, retailers, manufacturers and exporters in Australia. The Hemp Foods Australia has a product range, including hemp seeds, hemp protein, hemp oil and hemp flour. The firm also manufactures hemp-based Sativa skincare range, as well as its plant-based Burger range.
